摘要
目的:比较穴位埋线与坤泰胶囊治疗围绝经期综合征的临床疗效差异,为围绝经期综合征的治疗提供有效疗法。方法:埋线组33例行穴位埋线治疗,以肝脾肾俞募配穴为主方,配合辨证和辨病取穴相结合,10天埋线1次;坤泰胶囊组口服坤泰胶囊,每次4粒,每天3次,分别在治疗前、治疗10天、30天和60天时观察两组患者Kupperman指数(KI)评分,并根据KI比值的改变评定疗效。结果:治疗后两组均随着治疗时间的延长,KI评分、KI比值逐渐下降,且治疗10天后埋线组KI评分、KI比值均低于坤泰胶囊组(均P<0.05);治疗10天后,埋线组总有效率为36.4%(12/33),优于坤泰胶囊组的3.0%(1/33,P<0.05),而治疗30天后、60天后以上各项指标组间差异均无统计学意义(均P>0.05)。结论:穴位埋线与坤泰胶囊均可降低KI评分,改善患者临床症状,且穴位埋线在治疗早期有一定疗效优势。
Objective To compare the clinical efficacy differences between acupoint catgut embedding and Kuntai capsule for perimenopausal syndrome, so as to provide an effective treatment method for perimenopausal syndrome. Methods Thirty-three cases in the embedding group were treated with acupoint catgut embedding at back-shu points and front-mu points of liver, spleen and kidney combined with syndrome differentiation and disease differentiation, ten days per times; the Kuntai group was treated with oral administration of Kuntai capsule, 4 capsules each time, three times per day. The Kupperman index (KI) was observed in the two groups before treatment after 10 days, 30 days and 60 days of treatment, respectively; the efficacy was evaluated according to the ratio of KI. Results After the treatment, as treat- ment proceeded, the score of KI and ratio of KI were gradually reduced in two groups; the score of KI and ratio of KI in the embedding group after 10 days of treatment was lower than those in the Kuntai group (both P〈0. 05) ; after 10 clays of treatment, the total effective rate was 36.4% (12/33) in the embedding group, which was superior to 3.0% (1/33) in the Kuntai group (P〈0.05) ; however, after 30 days and 60 days of treatment, the differences of each index between two groups were not statistically significant (all P〉0.05). Conclusion Both the acupoint catgut embedding and Ku^tai cap- sule could reduce the score of KI and improve clinical symptoms, and the acupoint catgut embedding has certain advantage on the early stage of treatment.
出处
《中国针灸》
CAS
CSCD
北大核心
2014年第10期961-964,共4页
Chinese Acupuncture & Moxibustion
基金
江苏大学医学临床科技发展基金项目:JLY20120166